A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).
| Image |  |
|---|---|
| Description | scientific article published on 8 November 2006 |
| Author/s |
author: Margaret A Fischl J. Michael Kilby |
| Publication date | November 8, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |